NCMI CEO Tom Lesinski to retire Dec 31, 2026; board hires Korn Ferry to lead successor search
National CineMedia, Inc.
Thomas F. Lesinski will retire as Chief Executive Officer and step off the Board, with anticipated departure December 31, 2026; he remains CEO through the transition.
Board retained search firm Korn Ferry to identify a successor CEO; no replacement has been named.
Transition and Separation Agreement dated Nov 9, 2026: $3,000,000 severance paid over 12 months after departure, COBRA up to 12 months, and eligibility for the 2026 annual bonus.
Outstanding equity awards vest pro-rata through the Transition Date; performance stock units remain eligible to vest based on actual performance.
Lesinski joined the Board in 2014 and became CEO in 2019; he cited the closing of the Captivate acquisition as the right time to hand over leadership.
On November 10, 2026, National CineMedia, Inc. (the “ Company ”) announced that Thomas F. Lesinski, the Company’s Chief Executive Officer, will retire as part of a transition plan from his position as Chief Executive Officer and as a member of the Board of Directors (the “ Board ”), with an anticipated departure of December 31, 2026 (the “ Transition Date ”).
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.97
Thomas F. Lesinski departed as Chief Executive Officer at National CineMedia, Inc..
Action
retire
Role
Chief Executive Officer
Exact text from the filing
On November 10, 2026, National CineMedia, Inc. (the “ Company ”) announced that Thomas F. Lesinski, the Company’s Chief Executive Officer, will retire as part of a transition plan from his position as Chief Executive Officer and as a member of the Board of Directors (the “ Board ”), with an anticipated departure of December 31, 2026 (the “ Transition Date ”).
This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.